Literature DB >> 4351926

Humoral factors influencing cell-mediated immune responses to tumour-associated antigens.

R W Baldwin, M J Embleton, R A Robins.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4351926      PMCID: PMC1644958     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


× No keyword cloud information.
  7 in total

1.  Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes.

Authors:  R W Baldwin; M R Price; R A Robins
Journal:  Nat New Biol       Date:  1972-08-09

2.  Solubilization of tumour-specific antigen from plasma membrane of an aminoazo-dye-induced rat hepatoma.

Authors:  R W Baldwin; D Glaves
Journal:  Clin Exp Immunol       Date:  1972-05       Impact factor: 4.330

3.  Demonstration of cell-surface antigens on chemically induced tumors.

Authors:  R W Baldwin; C R Barker; M J Embleton; D Glaves; M Moore; M V Pimm
Journal:  Ann N Y Acad Sci       Date:  1971-06-21       Impact factor: 5.691

4.  "Unblocking" serum activity in vitro in the polyoma system may correlate with antitumour effects of antiserum in vivo.

Authors:  S C Bansal; H O Sjögren
Journal:  Nat New Biol       Date:  1971-09-15

5.  Cellular immunity and its serum-mediated inhibition in Shope-virus-induced rabbit papillomas.

Authors:  I Hellström; C A Evans; K E Hellström
Journal:  Int J Cancer       Date:  1969-09-15       Impact factor: 7.396

6.  Elution of "blocking factors" from human tumors, capable of abrogating tumor-cell destruction by specifically immune lymphocytes.

Authors:  H O Sjögren; I Hellström; S C Bansal; G A Warner; K E Hellström
Journal:  Int J Cancer       Date:  1972-03-15       Impact factor: 7.396

7.  Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms.

Authors:  I Hellström; H O Sjögren; G Warner; K E Hellström
Journal:  Int J Cancer       Date:  1971-03-15       Impact factor: 7.396

  7 in total
  2 in total

1.  Characteristics of complexes for arming and inhibiting effector cells for antibody-dependent cell-mediated cytotoxicity.

Authors:  L Walker; F C Hay; I M Roitt
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

2.  Subversion of host defense mechanisms by malignant tumors: an established tumor as a privileged site for bacterial growth.

Authors:  G L Spitalny; R J North
Journal:  J Exp Med       Date:  1977-05-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.